|
0
|
|
RHOT1/2-driven mitochondrial membrane vesicles confer tumor-homing selectivity and enable in situ cancer vaccination.
(nature.com)
|
Meng W
…
Li L
Nature Communications
2026-07-23
|
#cancer
#immunotherapy
#nanoparticles
#vaccination
#mitochondria
|
|
0
|
|
Combination of exosome vaccines, lenvatinib, and anti-PD-1 eradicates tumor in autochthonous hepatocellular carcinoma mice.
(linkinghub.elsevier.com)
|
Zuo B
…
Yin H
Cell Reports Medicine
2026-07-23
|
#immunotherapy
#hepatocellular carcinoma
#exosome
#vaccination
#dendritic cell
|
|
0
|
|
Investigating the role of baseline gut Akkermansia muciniphila and its co-metabolite palmitoleic acid in BCG vaccine efficacy: a preclinical study.
(linkinghub.elsevier.com)
|
Chen D
…
Ge Z
EBioMedicine
2026-07-23
|
#microbiome
#vaccination
#tb
#metabolomics
#immunity
|
|
0
|
|
EscaPRRS-ORF5: A Structure-Aware Evolutionary Framework for Prioritizing Immune Escape-Prone Variants in Porcine Reproductive and Respiratory Syndrome Virus.
(academic.oup.com)
|
S R V
…
Chowdhury R
Bioinformatics
2026-07-23
|
#virulence
#evolution
#vaccination
#immunity
#prediction
|
|
0
|
|
Phase 2 Randomized Bivalent RSVpreF Maternal Vaccine Trial: Final Safety, Antibody Persistence and Efficacy.
(academic.oup.com)
|
Simoes EAF
…
Gurtman AC
Journal of Infectious Diseases
2026-07-23
|
#vaccination
#rsv
#clinical trial
#immunogenicity
#maternal
|
|
0
|
|
Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers.
(nature.com)
|
Capella-Pujol J
…
Sliepen K
Nature Communications
2026-07-23
|
#vaccination
#hepatitis
#immunogenicity
#protein design
#neutralization
|